Cardiol Therapeutics Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Cardiol Therapeutics Inc. now
Current reporting with the operating signal separated from the noise.
GuruFocus
Tejara Capital Ltd Expands Stake in Cardiol Therapeutics Inc (CR
The story matters when it changes Cardiol Therapeutics Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest CRDL filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
6-KOfficial SEC filingFiled 2026-09-23 · Period 2026-09-23SEC ↗6-KOfficial SEC filingFiled 2026-09-16 · Period 2026-09-16SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-09-23SEC ↗SUPPLOfficial SEC filingFiled 2026-09-16SEC ↗F-10/AOfficial SEC filingFiled 2026-09-16SEC ↗6-KOfficial SEC filingFiled 2026-09-15 · Period 2026-09-14SEC ↗6-KOfficial SEC filingFiled 2026-09-11 · Period 2026-09-10SEC ↗6-KOfficial SEC filingFiled 2026-09-10 · Period 2026-09-10SEC ↗
Cardiol Therapeutics Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →